Synthesis and Biological Evaluation of New Diarylpyrazole and Triarylimidazoline Derivatives as Selective COX-2 Inhibitors

被引：19
|
作者：
Abdellatif, Khaled R. A. [1 ,2 ]
Abdelgawad, Mohamed A. [1 ,3 ]
Labib, Madlen B. [1 ]
Zidan, Taha H.
机构：
[1] Beni Suef Univ, Fac Pharm, Dept Organ Pharmaceut Chem, Bani Suwayf 62514, Egypt
[2] Ibn Sina Natl Coll Med Studies, Dept Pharmaceut Sci, Jeddah, Saudi Arabia
[3] Aljouf Univ, Coll Pharm, Dept Pharmaceut Chem, Sakaka, Aljouf, Saudi Arabia
来源：
ARCHIV DER PHARMAZIE | 2017年 / 350卷 / 08期
关键词：
Anti-inflammatory; Imidazoline; Pyrazole; Selective COX-2 inhibitor; DONOR ESTER PRODRUGS; ANTIINFLAMMATORY EVALUATION; CYCLOOXYGENASE INHIBITION; DESIGN;
D O I：
10.1002/ardp.201600386
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
New series of diarylpyrazoles 8a-f and triarylimidazoline-5-ones 11a-g were synthesized and evaluated for their in vitro cyclooxygenase-1 (COX-1) and COX-2 inhibitory activity and in vivo anti-inflammatory activity. The synthesized compounds showed good selectivity for COX-2; compounds 8a, 8d, 8f, 11a, and 11c exhibited the highest COX-2 selectivity indexes (SI=4.77-5.43) compared to the reference drug celecoxib (SI=7.8). All compounds showed good in vivo anti-inflammatory activity, especially compounds 8a, 8f, 11c, and 11d, which also showed some similarities to the time interval pattern of celecoxib at all different time intervals (1, 3, and 6h).
引用
收藏
页数：10
相关论文
共 50 条
  • [31] MEDI 192-Synthesis and biological evaluation of phenylazo benzenesulfonamides as selective COX-2 inhibitors
    Lin, Shwu-Jiuan
    Yang, Li-Ming
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232
  • [32] Hybrids of selective COX-2 inhibitors and active derivatives of edaravone as COX-2 selective NSAIDs with free radical scavenging activity: Design, synthesis and biological activities
    Wang, Youzhi
    Yang, Guoqing
    Shen, Huizhen
    Liang, Ying
    Dong, Haijuan
    Guo, Ximing
    Hao, Qingjing
    Wang, Jinxin
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 266
  • [33] Synthesis, Biological Activity, and Molecular Modeling Studies of Pyrazole and Triazole Derivatives as Selective COX-2 Inhibitors
    Assali, Mohyeddin
    Abualhasan, Murad
    Sawaftah, Hadeel
    Hawash, Mohammed
    Mousa, Ahmed
    JOURNAL OF CHEMISTRY, 2020, 2020
  • [34] Design and biological evaluation of novel hybrids of 1, 5-diarylpyrazole and Chrysin for selective COX-2 inhibition
    Ren, Shen-Zhen
    Wang, Zhong-Chang
    Zhu, Xiao-Hua
    Zhu, Dan
    Li, Zhang
    Shen, Fa-Qian
    Duan, Yong-Tao
    Cao, Han
    Zhao, Jing
    Zhu, Hai-Liang
    BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (14) : 4264 - 4275
  • [35] Synthesis, biological evaluation and molecular modeling study of pyrazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents
    Tewari, Ashish Kumar
    Singh, Ved Prakash
    Yadav, Pratima
    Gupta, Garima
    Singh, Amit
    Goel, Raj Kumar
    Shinde, Pravin
    Mohan, C. Gopi
    BIOORGANIC CHEMISTRY, 2014, 56 : 8 - 15
  • [36] SYNTHESIS AND PHARMACOLOGY OF SELECTIVE COX-2 INHIBITORS
    ISAKSON, PC
    MEDICINAL CHEMISTRY RESEARCH, 1995, 5 (05) : 344 - 350
  • [37] SYNTHESIS AND PHARMACOLOGY OF SELECTIVE COX-2 INHIBITORS
    ISAKSON, P
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 270 - MEDI
  • [38] Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1,3,5-triarylpyrazoline and 1,5-diarylpyrazole derivatives as selective COX-2 inhibitors
    Abdellatif, Khaled R. A.
    Abdelall, Eman K. A.
    Fadaly, Wael A. A.
    Kamel, Gehan M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (02) : 406 - 412
  • [39] Synthesis, biological evaluation, and docking studies of novel heterocyclic diaryl compounds as selective COX-2 inhibitors
    Eren, Goekcen
    Unlu, Serdar
    Nunez, Maria-Teresa
    Labeaga, Luis
    Ledo, Francisco
    Entrena, Antonio
    Banoglu, Erden
    Costantino, Gabriele
    Sahin, M. Fethi
    BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (17) : 6367 - 6376
  • [40] Design, synthesis, biological evaluation, and docking studies of some novel chalcones as selective COX-2 inhibitors
    Kaya Cavusoglu, Betul
    Saglik, Begum N.
    Acar Cevik, Ulviye
    Osmaniye, Derya
    Levent, Serkan
    Ozkay, Yusuf
    Kaplancikli, Zafer A.
    ARCHIV DER PHARMAZIE, 2021, 354 (03)
12345